Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

494
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
494
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

422
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
422
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

370
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
370
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

798
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
798
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

730
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

243
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
243

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Normal standardized left ventricular longitudinal strain curves stratified by age and sex in healthy individuals: The Copenhagen City Heart Study.

European heart journal. Cardiovascular Imaging·2026
Same author

GLP-1 receptor agonists in patients with Type 2 diabetes: cardiorenal protection versus ocular safety.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

Diabetes, obesity & metabolism·2026
Same author

Inter-arm Blood Pressure Difference is Associated With Both Coronary Artery Disease and Peripheral Artery Disease in People With HIV.

Open forum infectious diseases·2026
Same author

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Diabetes care·2026
Same author

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Nephrology in the Paradigm of Cardiovascular-Kidney-Metabolic Health: Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Genetic Risk Factors for Kidney Function in Individuals with Type 1 Diabetes.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

How I Treat a Patient with Primary Aldosteronism.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Major Adverse Kidney Events in the American Indian or Alaska Native Population with Diabetes.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

Atrial Fibrillation and Stroke Prevention and Management in Chronic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same journal

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

Clinical journal of the American Society of Nephrology : CJASN·2026
查看所有相关文章

相关实验视频

Updated: Feb 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

在患有慢性病的人群中,劳动力分离.

Rasmus Rørth1, Milos M Koch2, Thomas A Gerds1,2

  • 1Steno Diabetes Center Copenhagen, Copenhagen, Denmark.

Clinical journal of the American Society of Nephrology : CJASN
|February 17, 2026
PubMed
概括
此摘要是机器生成的。

患有慢性病 (CKD) 的人面临离开劳动力的风险明显更高. 早期发现和治疗CKD的干预措施对于减轻这种影响至关重要.

更多相关视频

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

相关实验视频

Last Updated: Feb 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 公共卫生 公共卫生
  • 职业医学 职业医学是专业的.

背景情况:

  • 功能受损与不良健康结果有关,包括死亡率和生活质量下降.
  • 就业状态与财务稳定,健康和个人身份密切相关.
  • 功能与劳动力参与之间的关系需要进一步研究.

研究的目的:

  • 检查慢性病 (CKD) 状态和CKD阶段与劳动力离职之间的关联.
  • 在患有CKD的劳动年龄人口中估计劳动力分离的绝对风险.

主要方法:

  • 使用每周更新的职业状态数据,结合实验室结果和国家注册.
  • 在劳动年龄人口 (18-60岁) 中估计的功能.
  • 使用阿伦-约翰森估计器来计算退休和死亡的竞争风险.

主要成果:

  • 患有CKD的个人表现出更高的劳动力分离的绝对风险 (一年风险:9%与5%相比,p<0.001).
  • 劳动力分离的风险随着CKD严重程度的增加而增加,从5% (eGFR>60) 到20% (CKD阶段G5).
  • 诸如年龄较大,女性性别,糖尿病和教育水平较低等因素与劳动力分离的增加有关.

结论:

  • 与正常功能相比,CKD显著增加了劳动力脱离的可能性.
  • 这凸显了CKD的未被认可的负担.
  • 强调急需早期检测和治疗CKD的干预措施.